Orexo

Orexo’s Opioid Overdose Nasal Spray Fails FDA Review for Second Time
BioSpace
Wed, 07/17/24 - 12:16 pm
Orexo
opioids
opioid overdose
FDA
OX124
Orexo eyes real-world testing of its modia opioid use disorder app
Pharmaforum
Fri, 02/12/21 - 10:41 am
Orexo
opioids
opioid use disorder
digital therapeutics
cognitive behavioral therapy
Modia
Orexo eyes opioid use disorder app launch before year-end
Pharmaforum
Fri, 10/2/20 - 01:02 pm
Orexo
opioid use disorder
opioids
digital therapeutics
Orexo launches digital therapies for depression, alcohol misuse early in US
Pharmaforum
Fri, 07/17/20 - 10:46 am
Orexo
digital therapies
COVID-19
depression
alcoholism
Orexo eyes launch of digital therapy for heavy drinkers this year
Pharmaforum
Wed, 03/11/20 - 10:49 am
Orexo
alcoholism
FDA
digital therapeutics
Addiction firm Orexo licenses app for alcohol use disorder
Pharmaforum
Fri, 11/29/19 - 02:23 pm
Orexo
opioid addiction
digital therapy
Vorvida
Orexo partners with Gaia on digital opioid abuse therapeutic
Pharmaforum
Fri, 08/23/19 - 09:53 am
Orexo
Gaia Healthcare
digital therapeutics
opioid use disorder
opioid addiction
Orexo Wins U.S. Backing for Opioid-Addiction Tablet
Bloomberg
Thu, 07/4/13 - 11:16 am
Orexo
opiod addiciton
FDA
Zubsolv
Galena Biopharma: David Battles Goliath
Seeking Alpha
Wed, 06/19/13 - 03:47 pm
Galena Biopharma
breast cancer
Teva
cancer pain
Orexo
Galena pays $10M upfront to license Abstral, a treatment for severe episodes of cancer pain
Yahoo/AP
Mon, 03/18/13 - 11:09 am
Galena Biopharma
Abstral
cancer pain
Orexo
Orexo Falls as Much as 20% After J&J Drug Research Deal Canceled
Bloomberg
Tue, 01/31/12 - 07:49 am
Orexo
JNJ
COPD Drug Class Gasping for Breath
WSJ Online
Thu, 04/8/10 - 10:47 am
COPD
Forest Labs
Nycomed
Otsuka
Glenmark
Orexo